These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7535608)

  • 1. Chemotherapy in head and neck cancer.
    Merlano M; Benasso M; Cavallari M; Blengio F; Rosso M
    Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):283-9. PubMed ID: 7535608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of head and neck cancer.
    Nwizu T; Adelstein D
    Expert Opin Pharmacother; 2015; 16(16):2409-22. PubMed ID: 26513647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
    Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR
    Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and combined modality therapy in head and neck cancer.
    Hamasaki VK; Vokes EE
    Curr Opin Oncol; 1993 May; 5(3):508-17. PubMed ID: 8494912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
    Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
    J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts for the management of head and neck cancer: chemotherapy.
    Specenier PM; Vermorken JB
    Oral Oncol; 2009; 45(4-5):409-15. PubMed ID: 18715812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy for head and neck cancer: recent data.
    Vokes EE
    Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy for squamous cell head and neck cancer: a neverending story?
    Benasso M
    Oral Oncol; 2013 Aug; 49(8):747-52. PubMed ID: 23683948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Docetaxel and squamous cell carcinoma of the head and neck].
    Calais G
    Bull Cancer; 2004 Feb; 91(2):167-71. PubMed ID: 15047456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck.
    Clark JR; Dreyfuss AI
    Semin Oncol; 1991 Feb; 18(1 Suppl 3):34-48. PubMed ID: 2003226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
    Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.
    Cancer; 1987 Aug; 60(3):301-11. PubMed ID: 2885080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
    Kies MS
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy advances in head and neck oncology.
    Liggett W; Forastiere AA
    Semin Surg Oncol; 1995; 11(3):265-71. PubMed ID: 7638514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.